EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle

Yiangos Psaras, Christopher N Toepfer iD

Experimental Physiology · 2024-02 · 109 (2) · 175-189

DOI: 10.1113/ep090436 ↗

At a glance

Übersichtsarbeit in Experimental Physiology, published online on 2023-12-14. Written by Yiangos Psaras and 1 co-authors. Institution: Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. Major MEDLINE topics: Muscle, Skeletal, Muscular Dystrophy, Duchenne. Cited 3 times so far (Crossref); 108 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Skeletal myopathies and ataxias with secondary cardiac involvement are complex, progressive and debilitating conditions. As life expectancy increases across these conditions, cardiac involvement often becomes more prominent. This highlights the need for targeted therapies that address these evolving cardiac pathologies. Musculopathies by and large lack cures that directly target the genetic basis of the diseases; however, as our understanding of the genetic causes of these conditions has evolved, it has become tractable to develop targeted therapies using biologics, to design precision approaches to target the primary genetic causes of these varied diseases. Using the examples of Duchenne muscular dystrophy, Friedreich ataxia and Pompe disease, we discuss how the genetic causes of such diseases derail diverse homeostatic, energetic and signalling pathways, which span multiple cellular systems in varied tissues across the body. We outline existing therapeutics and treatments in the context of emerging novel genetic approaches. We discuss the hurdles that the field must overcome to deliver targeted therapies across the many tissue types affected in primary myopathies.

Subjects

MeSH terms (MEDLINE)

Muscle, SkeletalMuscular Dystrophy, DuchenneHumansHeartGenetic Therapy

Author keywords

Duchenne muscular dystrophyFriedreich's ataxiaPompe diseasegene therapyskeletal and cardiac muscle diseasetherapeutics

Authors and institutions

  • Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

ORCID profiles: Christopher N Toepfer

Funding

  • Wellcome Trust

Cite

APA

Psaras, Y., & Toepfer, C. N. (2024). Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle. Experimental Physiology, 109(2), 175-189. https://doi.org/10.1113/ep090436

Vancouver

Psaras Y, Toepfer CN. Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle. Experimental Physiology. 2024;109(2):175-189. doi:10.1113/ep090436

BibTeX
@article{Psaras2024,
  author = {Psaras, Yiangos and Toepfer, Christopher N},
  title = {Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle},
  journal = {Experimental Physiology},
  year = {2024},
  volume = {109},
  number = {2},
  pages = {175--189},
  doi = {10.1113/ep090436}
}
Start for free →